RxDoctor Payments Data

Mark Bowling, MD

Family Medicine · Independence, KYNPI 1982657219

Payments from drug & device makers

$7,208in general payments, 2019–2025

Across 453 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Amgen$503
  • Lilly USA, LLC$501
  • Pfizer$484
  • GSK$342
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$7,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,208 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$48,434
Medicare patients
184
Services billed
1,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$82,633
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$54,730
EliquisApixaban48$40,129
MounjaroTirzepatide21$28,512
JanuviaSitagliptin Phosphate19$24,752
JardianceEmpagliflozin20$24,307
Tresiba Flextouch U-200Insulin Degludec15$20,997
FarxigaDapagliflozin Propanediol14$17,784
XareltoRivaroxaban11$13,487
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$7,949
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$6,890
Novolog FlexpenInsulin Aspart12$5,820
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$4,602
Albuterol Sulfate HfaAlbuterol Sulfate124$3,363
Metoprolol Succinate172$2,806

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,103$82,63356 claims
GSKTrelegy Ellipta$342$54,73084 claims
PfizerEliquis$484$40,12948 claims
Lilly USA, LLCMounjaro$501$28,51221 claims
MerckJanuvia$76$24,75219 claims
Boehringer IngelheimJardiance$263$24,30720 claims
AstraZenecaFarxiga$236$17,78414 claims
Johnson & JohnsonXarelto$100$13,48711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Independence

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →